1.Study on knowledge, attitudes, and practice of tobacco control of medical staff in Gansu prov-ince
Jiuling LI ; Gexiang ZHANG ; Zeshan ZHU ; Peijun LU ; Li WANG ; Xingrong LIU
Chinese Journal of Health Policy 2014;(10):73-77
Objective:Through a study on knowledge, attitudes, and practice of tobacco control of medical staff in Gansu Province, the paper aims to analyze the issues of participation, community tobacco control leadership and other aspects that impact the creation of a smoke-free healthcare system in order to provide a basis for the formulation of policies to improve the health professional mechanism of tobacco control. Methods:The stratified cluster sampling method was adopted to select 34 companies, accounting for a total of 805 medical staff as the study population in all kinds of health institutions. A self-designed questionnaire was adopted to investigate their knowledge, attitudes, and practice via on-site self-administered surveys. Results:the medical staff lacks knowledge as to the depth and breadth of damage from the use of tobacco. Although their attitude towards tobacco control is positive, the comprehensive to-bacco control service capabilities are insufficient. Logistic regression analysis showed that tobacco control capabilities of medical staff is related to their attitude toward smoking and whether or not they discourage smoking or asking about smoking . Conclusion:The key to the creation of a smoke-free health system to lead the community in tobacco control is the targeted tobacco cessation knowledge and skills training of medical staff to reduce smoking rates among medical staff and enhance the awareness of administrative staff.
2.The synergistic effect of FGF-21 and insulin on regulating glucose metabolism and its mechanism.
Dan YU ; Cuiyu SUN ; Guopeng SUN ; Guiping REN ; Xianlong YE ; Shenglong ZHU ; Wenfei WANG ; Pengfei XU ; Shujie LI ; Qiang WU ; Zeshan NIU ; Tian SUN ; Mingyao LIU ; Deshan LI
Acta Pharmaceutica Sinica 2014;49(7):977-84
Previous studies proposed that the synergistic effect of fibroblast growth factor-21 (FGF-21) and insulin may be due to the improvement of insulin sensitivity by FGF-21. However, there is no experimental evidence to support this. This study was designed to elucidate the mechanism of synergistic effect of FGF-21 and insulin in the regulation of glucose metabolism. The synergistic effect of FGF-21 and insulin on regulating glucose metabolism was demonstrated by investigating the glucose absorption rate by insulin resistance HepG2 cell model and the blood glucose chances in type 2 diabetic db/db mice after treatments with different concentrations of FGF-21 or/and insulin; The synergistic metabolism was revealed through detecting GLUT1 and GLUT4 transcription levels in the liver by real-time PCR method. The experimental results showed that FGF-21 and insulin have a synergistic effect on the regulation of glucose metabolism. The results of real-time PCR showed that the effective dose of FGF-21 could up-regulate the transcription level of GLUT1 in a dose-dependent manner, but had no effect on the transcription level of GLUT4. Insulin (4 u) alone could up-regulate the transcription level of GLUT4, yet had no effect on that of GLUT1. Ineffective dose 0.1 mg kg(-1) FGF-21 alone could not change the transcription level of GLUT1 or GLUT4. However, when the ineffective dose 0.1 mg x kg(-1) FGF-21 was used in combination with insulin (4 u) significantly increased the transcription levels of both GLUT1 and GLUT4, the transcription level of GLUT1 was similar to that treated with 5 time concentration of FGF-21 alone; the transcription level of GLUT4 is higher than that treated with insulin (4 u) alone. In summary, in the presence of FGF-21, insulin increases the sensitivity of FGF-21 through enhancing GLUT1 transcription. Vice versa, FGF-21 increases the sensitivity of insulin by stimulating GLUT4 transcription in the presence of insulin. FGF-21 and insulin exert a synergistic effect on glucose metabolism through mutual sensitization.
3.Effect of Chinese Medicine on Signaling Pathways Related to Hepatocellular Carcinoma and Its Potential Mechanism: A Review
Peirong QIU ; Zeshan CHEN ; Wenlin ZHU ; Peichun PENG ; Jitian WU ; Yulian LI ; Xin DENG
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(23):264-272
Hepatocellular carcinoma (HCC), an insidious malignant tumor with high incidence and lethality, poses a major threat to physical and mental health of human beings. The pathological mechanism needs to be further studied. Surgery, radiotherapy, chemotherapy, and targeted drugs are effective but induce many adverse reactions. Traditional Chinese medicine (TCM) has unique advantages and abundant clinical experience in the treatment of HCC. There has been an explosion of research on the pathways, targets, and mechanism of TCM against HCC from the perspective of molecular biology. According to previous research, Chinese medicinals or compound Chinese medicine prescriptions, directly or indirectly prevent the occurrence and progression of HCC through multiple pathways and targets, which is closely related to the pathophysiological processes such as cell proliferation, metastasis, apoptosis, autophagy, inflammatory response, and immune response. This paper summarizes and analyzes research on the action pathways and mechanisms of Chinese medicine against HCC. Specifically, isoliquiritigenin, dendrobium candidum and Yexiazhu compound Ⅱ regulate phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathway to inhibit the growth, proliferation and metastasis of tumor cells. Toad venom and dioscorea zingiberensis induce and enhance HCC autophagy by modulating mammalian target of rapamycin (mTOR) signaling pathway. Myricetin, asparagus, and Biejiajian Wan regulate mitogen-activated protein kinase (MAPK) signaling pathway to promote HCC cell cycle arrest, inhibit angiogenesis, and induce apoptosis. Polygonum odoratum, tetragonum, and plantainoside modulate nuclear factor-kappa B (NF-κB) to inhibit inflammatory response and HCC metastasis and reduce drug resistance. Quercetin and erigeron breviscapus control the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway to suppress epithelial-mesenchymal transition (EMT) and remodel cytoskeleton. This paper is expected to lay a theoretical basis for the in-depth research on and clinical application of Chinese medicine in the treatment of HCC.